Bruggink J - Search Results

1

Phase I trial of 5-fluorouracil and dipyridamole administered by seventy-two-hour concurrent continuous infusion.

Remick SC, Grem JL, Fischer PH, Tutsch KD, Alberti DB, Nieting LM, Tombes MB, Bruggink J, Willson JK, Trump DL. Remick SC, et al. Among authors: bruggink j. Cancer Res. 1990 May 1;50(9):2667-72. Cancer Res. 1990. PMID: 2328492

2

Phase I clinical trial of fazarabine as a twenty-four-hour continuous infusion.

Bailey H, Tutsch KD, Arzoomanian RZ, Tombes MB, Alberti D, Bruggink J, Wilding G. Bailey H, et al. Among authors: bruggink j. Cancer Res. 1991 Feb 15;51(4):1105-8. Cancer Res. 1991. PMID: 1705165 Clinical Trial.

3

Methotrexate and dipyridamole combination chemotherapy based upon inhibition of nucleoside salvage in humans.

Willson JK, Fischer PH, Remick SC, Tutsch KD, Grem JL, Nieting L, Alberti D, Bruggink J, Trump DL. Willson JK, et al. Among authors: bruggink j. Cancer Res. 1989 Apr 1;49(7):1866-70. Cancer Res. 1989. PMID: 2924325

4

Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage.

Willson JK, Fischer PH, Tutsch K, Alberti D, Simon K, Hamilton RD, Bruggink J, Koeller JM, Tormey DC, Earhart RH, et al. Willson JK, et al. Among authors: bruggink j. Cancer Res. 1988 Oct 1;48(19):5585-90. Cancer Res. 1988. PMID: 3416311

5

Biochemical assessment of the effects of acivicin and dipyridamole given as a continuous 72-hour intravenous infusion.

Fischer PH, Willson JK, Risueno C, Tutsch K, Bruggink J, Ranhosky A, Trump DL. Fischer PH, et al. Among authors: bruggink j. Cancer Res. 1988 Oct 1;48(19):5591-6. Cancer Res. 1988. PMID: 3416312

6

Structure-activity analysis of antagonism of the feedback inhibition of thymidine kinase.

Fischer PH, Fang TT, Lin TS, Hampton A, Bruggink J. Fischer PH, et al. Among authors: bruggink j. Biochem Pharmacol. 1988 Apr 1;37(7):1293-8. doi: 10.1016/0006-2952(88)90785-x. Biochem Pharmacol. 1988. PMID: 3355601

7

Biphasic insulin secretion after intravenous but not after intraportal CCK-8 infusion in rats.

Balkan B, Steffens AB, Strubbe JH, Bruggink JE. Balkan B, et al. Among authors: bruggink je. Diabetes. 1990 Jun;39(6):702-6. doi: 10.2337/diab.39.6.702. Diabetes. 1990. PMID: 2189762

8

Insulin levels after portal and systemic insulin infusion differ in a dose-dependent fashion.

De Vos P, De Haan BJ, Vegter D, Hillebrands JL, Strubbe JH, Bruggink JE, Van Schilfgaarde R. De Vos P, et al. Among authors: bruggink je. Horm Metab Res. 1998 Dec;30(12):721-5. doi: 10.1055/s-2007-978966. Horm Metab Res. 1998. PMID: 9930629

9

Daily variation of food-induced changes in blood glucose and insulin in the rat and the control by the suprachiasmatic nucleus and the vagus nerve.

Strubbe JH, Prins AJ, Bruggink J, Steffens AB. Strubbe JH, et al. Among authors: bruggink j. J Auton Nerv Syst. 1987 Aug;20(2):113-9. doi: 10.1016/0165-1838(87)90108-1. J Auton Nerv Syst. 1987. PMID: 3312380

10

Exercise-induced sympathetic FFA mobilization in VMH-lesioned rats is normalized by fasting.

Balkan B, Van Dijk G, Strubbe JH, Bruggink JE, Steffens AB. Balkan B, et al. Among authors: bruggink je. Am J Physiol. 1992 Jun;262(6 Pt 2):R981-5. doi: 10.1152/ajpregu.1992.262.6.R981. Am J Physiol. 1992. PMID: 1621877 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters